Cargando…

Computational and In Vitro Analysis of Plumbagin’s Molecular Mechanism for the Treatment of Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is the fifth most common malignant tumor and the second leading cause of cancer-related death in the world. Plumbagin (PL) is a small molecule naphthoquinone compound isolated from Plumbago zeylanica L. that has important anticancer properties, but its mechanism requir...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wei, Yanfei, Lin, Yuning, Chen, Wanjun, Liu, Shasha, Jin, Lijie, Huang, Delun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8072012/ https://www.ncbi.nlm.nih.gov/pubmed/33912033 http://dx.doi.org/10.3389/fphar.2021.594833

Ejemplares similares

Plumbagin Restrains Hepatocellular Carcinoma Angiogenesis by Stromal Cell-Derived Factor (SDF-1)/CXCR4-CXCR7 Axis
por: Zhong, Jing, et al.
Publicado: (2019)

Plumbagin Exhibits Genotoxicity and Induces G2/M Cell Cycle Arrest via ROS-Mediated Oxidative Stress and Activation of ATM-p53 Signaling Pathway in Hepatocellular Cells
por: Liu, Huan, et al.
Publicado: (2023)

Plumbagin Prevents Secretory Diarrhea by Inhibiting CaCC and CFTR Channel Activities
por: Yu, Bo, et al.
Publicado: (2019)

Plumbagin restrains hepatocellular carcinoma angiogenesis by suppressing the migration and invasion of tumor-derived vascular endothelial cells
por: Wei, YanFei, et al.
Publicado: (2017)

Plumbagin inhibits proliferation and induces apoptosis of hepatocellular carcinoma by downregulating the expression of SIVA
por: Li, Tingting, et al.
Publicado: (2019)

Plumbagin promotes human hepatoma SMMC-7721 cell apoptosis via caspase-3/vimentin signal-mediated EMT
por: Wei, Yanfei, et al.
Publicado: (2019)

Plumbagin Alleviates Capillarization of Hepatic Sinusoids In Vitro by Downregulating ET-1, VEGF, LN, and Type IV Collagen
por: Li, Guiyu, et al.
Publicado: (2017)

Antimalarial activity of plumbagin in vitro and in animal models
por: Sumsakul, Wiriyaporn, et al.
Publicado: (2014)

Metal-organic frameworks for hepatocellular carcinoma therapy and mechanism
por: Feng, Yingqi, et al.
Publicado: (2022)

Anticancer Effects and Mechanisms of Action of Plumbagin: Review of Research Advances
por: Yin, Zhenhua, et al.
Publicado: (2020)

Anticancer Compound Plumbagin and Its Molecular Targets: A Structural Insight into the Inhibitory Mechanisms Using Computational Approaches
por: Jamal, Mohammad S., et al.
Publicado: (2014)

In Vivo and in vitro antitumor activity of tomatine in hepatocellular carcinoma
por: Echeverría, Cesar, et al.
Publicado: (2022)

Molecular mechanism of Ganji Fang in the treatment of hepatocellular carcinoma based on network pharmacology, molecular docking and experimental verification technology
por: Yang, Miaolun, et al.
Publicado: (2023)

Intracellular Reduction-Responsive Molecular Targeted Nanomedicine for Hepatocellular Carcinoma Therapy
por: Ding, Lei, et al.
Publicado: (2022)

Mechanisms of tumor-associated macrophages affecting the progression of hepatocellular carcinoma
por: Yuan, Yi, et al.
Publicado: (2023)

Anti-Tumor Effects of Carrimycin and Monomeric Isovalerylspiramycin I on Hepatocellular Carcinoma in Vitro and in Vivo
por: Jin, Yong, et al.
Publicado: (2021)

Analysis of the absorbed constituents and mechanism of liquidambaris fructus extract on hepatocellular carcinoma
por: Wang, Shuai, et al.
Publicado: (2022)

Uncovering the Mechanisms of Cryptotanshinone as a Therapeutic Agent Against Hepatocellular Carcinoma
por: Luo, Yi, et al.
Publicado: (2020)

The core role of macrophages in hepatocellular carcinoma: the definition of molecular subtypes and the prognostic risk system
por: Wang, Qiaona, et al.
Publicado: (2023)

The role of RNA modification in hepatocellular carcinoma
por: Feng, Qiang, et al.
Publicado: (2022)

Drug resistance mechanism of kinase inhibitors in the treatment of hepatocellular carcinoma
por: Jiang, Lei, et al.
Publicado: (2023)

Network pharmacology and in vitro experiments-based strategy to investigate the mechanisms of KangXianYiAi formula for hepatitis B virus-related hepatocellular carcinoma
por: Cao, Xu, et al.
Publicado: (2022)

Classification molecular subtypes of hepatocellular carcinoma based on PRMT-related genes
por: Liu, Liwen, et al.
Publicado: (2023)

Induction of Apoptosis by Metabolites of Rhei Radix et Rhizoma (Da Huang): A Review of the Potential Mechanism in Hepatocellular Carcinoma
por: Jiang, Huanyu, et al.
Publicado: (2022)

Plumbagin alleviates obesity‐related asthma: Targeting inflammation, oxidative stress, and the AMPK pathway
por: Zhang, Lijie, et al.
Publicado: (2023)

Cytotoxicity Mechanism of Two Naphthoquinones (Menadione and Plumbagin) in Saccharomyces cerevisiae
por: Castro, Frederico Augusto Vieira, et al.
Publicado: (2008)

Erratum: Drug resistance mechanism of kinase inhibitors in the treatment of hepatocellular carcinoma
por: Frontiers Production Office,
Publicado: (2023)

Investigations of nitazoxanide molecular targets and pathways for the treatment of hepatocellular carcinoma using network pharmacology and molecular docking
por: Khan, Shakeel Ahmad, et al.
Publicado: (2022)

Elucidating the mechanism behind and investigating the efficacy of Traditional Chinese Medicine and Traditional Tibetan Medicine in combination with standard therapeutics in hepatocellular carcinoma and cholangiocarcinoma in vitro
por: Suo, Huizhen, et al.
Publicado: (2022)

Immunotherapies for advanced hepatocellular carcinoma
por: Sun, Li-Yang, et al.
Publicado: (2023)

Integrating Network Pharmacology and Pharmacological Evaluation for Deciphering the Action Mechanism of Herbal Formula Zuojin Pill in Suppressing Hepatocellular Carcinoma
por: Guo, Wei, et al.
Publicado: (2019)

Plumbagin can potently enhance the activity of xanthine oxidase: in vitro, in vivo and in silico studies
por: Yue, Liang, et al.
Publicado: (2021)

Interpreting the Pharmacological Mechanisms of Huachansu Capsules on Hepatocellular Carcinoma Through Combining Network Pharmacology and Experimental Evaluation
por: Huang, Jihan, et al.
Publicado: (2020)

Plumbagin resurrect colistin susceptible against colistin-resistant Pseudomonas aeruginosa in vitro and in vivo
por: Wang, Yue, et al.
Publicado: (2022)

Formulation and Evaluation of Plumbagin-Loaded Niosomes for an Antidiabetic Study: Optimization and In Vitro Evaluation
por: Tyagi, Rama, et al.
Publicado: (2023)

Network Pharmacology and Pharmacological Evaluation Reveals the Mechanism of the Sanguisorba Officinalis in Suppressing Hepatocellular Carcinoma
por: Jiang, Nan, et al.
Publicado: (2021)

Study on the mechanism of action of Scutellaria barbata on hepatocellular carcinoma based on network pharmacology and bioinformatics
por: Yang, An-Yin, et al.
Publicado: (2023)

Methyl Gallate Suppresses the Migration, Invasion, and Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma Cells via the AMPK/NF-κB Signaling Pathway in vitro and in vivo
por: Liang, Huaguo, et al.
Publicado: (2022)

Plumbagin Enhances the Radiosensitivity of Tongue Squamous Cell Carcinoma Cells via Downregulating ATM
por: Pan, Shu-Ting, et al.
Publicado: (2021)

Mitochondrial toxicity evaluation of traditional Chinese medicine injections with a dual in vitro approach
por: Shen, Yunfu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_54orc1u2djhfil60bijas4gjco